m
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nothing going to waste, not even waste
| Subscribe To The Plain Dealer
Nothing going to waste, not even waste
Sunday, November 26, 2006
John Funk
Plain Dealer Reporter
As Ohio joins the national rush to make corn-fed automotive fuel, there are lingering questions about the net energy gain - or loss.
In other words, does it take more energy to make ethanol from corn than the biofuel gives back?
Early studies concluded the process lost energy, but as the technology and size of the distilleries have grown, most experts now think there is a net gain.
Estimates are that corn-based ethanol gives back between 1.2 and 1.67 units of energy for every unit of fossil-fuel-based energy used to plant, fertilize, harvest, transport, ferment and distill the crop into alcohol.
Actually, the energy math depends in part on what happens to all of the byproducts.
One ethanol plant now being built in Ohio - Harrison Ethanol LLC in Cadiz - aims to alter the energy calculus with a creative, if costly, circular technology.
The Harrison facility will include barns that can hold as many as 12,000 head of beef and dairy cattle. The animals will eat the tons of corn mush, known as dried distillers grain, left over from the ethanol production.
Typically, ethanol refineries have to ship this material either to distant feedlots or to other plants for commercial sale. By housing the cattle on site, Harrison Ethanol eliminates those costs.
Fattening cattle also creates unsavory byproducts - manure and urine - and in this case, a lot of them.
That's where an "anaerobic digester" comes in. Harrison Ethanol has obtained state permits to build and operate a large digester - a biochemical operation that can convert animal wastes into useful products. Harrison even has a $500,000 U.S. Department of Agriculture grant for the work.
The digester will handle about 50 million gallons of manure a year. That's about 60 flushes of the stables a day, according to state records, a bonanza for the digester's microorganisms that will generate thousands of cubic feet of combustible gas - methane and carbon dioxide.
The CO2 will be captured for commercial sale. The methane will fuel a boiler and a small power plant to run the fermentation and distillation equipment, and maybe even have some power left over.
The plan is for the feedlot and digester to gradually begin operations next spring, with ethanol production ramping up in the fourth quarter.
Wendel Dreve, director of Harrison Ethanol, has described the project as a "vertically integrated, agriculturally based industrial development."
To reach this Plain Dealer reporter:
jfunk@plaind.com, 216-999-4138
Ethanol production expected to have huge impact on Ohio's rural areas, corn farmers
| Subscribe To The Plain Dealer
Fields of fuel
Ethanol production expected to have huge impact on Ohio's rural areas, corn farmers
Sunday, November 26, 2006
John Funk
Plain Dealer Reporter
Ohio has joined the green revo lution - turning corn into lu crative automotive moon shine.
Six "biorefineries" are under construction in the state, with a combined annual capacity of 500 million gallons of 200-proof ethanol. Up to another half dozen have either been proposed or will be proposed, say industry experts and state officials.
All the ethanol will be blended into gasoline, either at a 10 percent ratio to clean up tailpipe emissions, or at 85 percent to produce even cleaner burning E85 for the growing fleet of flex-fuel cars that can run on gasoline or ethanol. The giant fermentation and distilling operations will also churn out tons of animal feed, known to agribusiness as dried distillers grain.
The economic impact is expected to be considerable. The construction costs alone come to an average of $1.50 per gallon of capacity, making a 50 million-gallon plant, for example, a $75 million project before interest costs are added.
Not only will the refineries create jobs paying $15 to $22 per hour in hard-pressed rural areas, but they also are expected to boost employment for trucking and rail companies that will move the corn in and the ethanol and animal feed out.
And they will improve the sales of natural gas suppliers, since the plants will use prodigious amounts of fuel. At least one project, Coshocton Ethanol LLC, is talking to companies that can capture and sell the pure carbon dioxide created by the fermentation process - about 152 tons per year.
With just six plants now being built, "there will be a couple hundred new jobs tied directly to the ethanol plants and maybe as many as 1,000 jobs from related companies," said Lt. Gov. Bruce Johnson. He heads the Ohio Department of Development, which is offering loan, grant and tax credit packages to ethanol producers.
In order to encourage ethanol consumption, the state has made outright grants to service stations - $350,000 last year and nearly $1 million this year - to help pay for E85 pumps, and to terminals and blenders that store and mix ethanol with gasoline. (The alcohol is typically added at fuel terminals, not at refineries.)
In the long term, biofuels such as ethanol will generate enough wealth to create a rural renaissance and a "knowledge-based rural economy," said Tom Door, undersecretary for rural development with the U.S. Department of Agriculture, at a renewable energy summit in Columbus last week. "Renewable energy is rural energy. This is the opportunity of a lifetime."
The push for ethanol was underway in the Corn Belt years before the Bush Administration focused on it as a biofuel for energy independence.
There are 109 working ethanol refineries across the Midwest. This year they are expected to produce about 5 billion gallons - up 1 billion from last year, said Kristin Brekke of the American Coalition for Ethanol. Another 61 ethanol refineries are under construction, she said, or will soon be under construction.
The growing demand for corn as an ethanol refinery feedstock has already pushed up prices for the kernels to levels that were once as sociated with droughts.
The cash price for Ohio corn last week was $3.40 to $3.54 per bushel, nearly twice the $1.80 per bushel that the state's farmers earned on average last year.
"Yes, it does help raise the price of corn and that is good for Ohio's farmers," said Johnson. "The alternative is to keep burning gasoline made from Saudi and Venezuela oil."
The voracious demand for corn created by the refineries has created critics, though.
The Earth Policy Institute warns that ethanol production will this year swallow 55 million tons, or about one-sixth of the total corn harvest, yet supply only 3 percent of the nation's automotive fuel. Since America's farms typically supply 70 percent of the world's corn ex ports, the impact of ethanol produc tion from corn will be global.
And new ethanol plants are breaking ground quickly - one on average every three days, wrote Lester Brown, president of the institute, earlier this month.
The federal Energy Department has set 12 billion gallons as the top limit for corn- based ethanol produc tion and has estab lished a generous R&D grant program for making ethanol from wood chips, switch grass and prairie grass.
On Nov. 1, the agency set aside $17 million for grants supporting research into micro organisms capable of breaking down cellulose into alcohol.
Ohio's new ethanol plants are not likely to make local corn prices spike, said Dwayne Siekman, executive director of the Ohio Corn Growers Association.
"Based on size of corn crop and where our corn goes [to other states], we can sustain the six plants without a problem," he said. "And you can throw in three more plants without affecting local prices."
But the nation will need to grow more corn - and will, said Siekman.
One of the largest of the refineries now under construction is the 110 million-gallon plant scheduled to open in early 2008 in Greenville, northwest of Dayton.
The project is unique in that it involves an oil company and an agribusiness.
The Andersons Inc., an agribusiness, signed a deal in October with a subsidiary of Marathon Oil Co. to jointly build the plant and perhaps others in the future. The Andersons will manage the Greenville facility and Marathon will distribute the ethanol.
"We have been using renewable fuels for more than 20 years and are the second-largest user of ethanol in the nation," said Marathon spokeswoman Linda Casey. "This partnership secures supply."
The Andersons already operates an ethanol plant in Michigan and a second in Indiana. It is considering a second Ohio plant near Marion.
Neill Mckinstray, vice president and general manager of the company's ethanol division, said the market for ethanol as an automotive fuel has a lot of room to grow.
"But fact is, the amount of corn-based ethanol will be limited by the corn supply," he said. "And yes, the price of corn is a significant factor in the cost of livestock production. But I would remind people that this whole ethanol business is based on our huge demand for fuel. We have to decide just how important is it to drive around in our SUVs."
To reach this Plain Dealer reporter:
jfunk@plaind.com, 216-999-4138
This my take on pinks, you can't fall in love with these stocks. you treat them like they are your worst enemy, always suspicious, and have an exit strategy, I plan on selling half at.0003 I have had my share of losers and that's because I married these stinky pinks, you buy a million shares and think all it has to do is go to .50 and I am rich, very rarely does that happen, flip and move and remember if you can make 10% profit on each trade you will make money
jgbuz
sublime and skeen are assistant mods on this board now, lets make some money and please no personal attacks.
thanks
jgbuz
OT: ya I have one of those its TRSI its worth $1.32 started off as TNGO
Jim this is the link to the chat if your intrested
http://www.ancestryalbum.com/livestockchat/
This term was used in the PR tonight (Intrinsic Value) so I googled it, and this is the meaning from investopedia.
http://www.investopedia.com/terms/i/intrinsicvalue.asp
1. The actual value of a company or an asset based on an underlying perception of its true value including all aspects of the business, in terms of both tangible and intangible factors. This value may or may not be the same as the current market value. Value investors use a variety of analytical techniques in order to estimate the intrinsic value of securities in hopes of finding investments where the true value of the investment exceeds its current market value.
2. For call options, this is the difference between the underlying stock's price and the strike price. For put options, it is the difference between the strike price and the underlying stock's price. In the case of both puts and calls, if the respective difference value is negative, the instrinsic value is given as zero.
1. For example, value investors that follow fundamental analysis look at both qualitative (business model, governance, target market factors etc.) and quantitative (ratios, financial statement analysis, etc.) aspects of a business to see if the business is currently out of favor with the market and is really worth much more than its current valuation.
2. Intrinsic value in options is the in-the-money portion of the option's premium. For example, If a call options strike price is $15 and the underlying stock's market price is at $25, then the intrinsic value of the call option is $10. An option is usually never worth less than what an option holder can receive if the option is exercised.
WOW WOW
No wonder I could not get filled today,
also 154 member marks for our site
JMCP Press Release Source: James Monroe Capital Corporation
James Monroe Capital Authorizes Stock Dividend
Wednesday November 22, 8:02 pm ET
CHICAGO--(BUSINESS WIRE)--James Monroe Corporation (Pink Sheets:JMCP - News) has authorized a stock dividend of its restricted shares of Originally New York, Inc. such that every holder of 2010 shares of the Company's issued and outstanding stock shall be entitled to receive 1 share of Originally New York, Inc. The record date of this dividend is December 12 and the pay date is December 27 of this year.
ONYI Chairman Taylor Moffitt said, "Chris McGovern and I will be leaving to focus on ONYI now, and we are bringing our JMCP shareholders with us. If you want to be in this party, the show's at ONYI. At some point in the future following the dividend, ONYI will be renamed 'James Monroe Capital Corporation.' This train's leaving, and we're all going to OTC BB town."
The dividend stock is unregistered and accordingly would be restricted. Restricted stock cannot be sold for a period of time, such as a year or two. This protects shareholder value. Following the holding period, restricted stock is also subject to selling limits proportionate to the size of the company. This also helps to protect share prices.
James Monroe Capital President Chris McGovern said, "We have our known broker list, and will follow the strictest procedures of accurate dividend practice."
Moffitt commented, "On a less positive note, with this dividend passing value up to shareholders, the soon-to-be-former JMCP will be losing some of its intrinsic value. It has a future that is uncertain. We will announce our plans for it after they have been determined. Overall this is an outstanding reason to give thanks: the dividend will make your net worth go up. However, if you have short-term investment intentions, you should use discretion. Also, shareholders should be advised that if they sell their stock before the execution date, which is yet to be determined by the NASD, they would not get the dividend. In that light, we hypothesize the trading volume to be short-term investors selling while long-term investors are buying. We're happy to gain long-term partners and accommodate the exit of the short-term market players. I hope all shareholders find us worthy of their continued partnership. I will continue to work diligently to care for OUR new company, ONYI. Happy Thanksgiving and God bless."
This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company's limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company's projections or forward-looking statements. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Contact:
James Monroe Capital Corporation, Northbrook, IL
Chris McGovern, 847-418-3848
--------------------------------------------------------------------------------
Source: James Monroe Capital Corporation
here it is NEWS NEWS
Press Release Source: James Monroe Capital Corporation
James Monroe Capital Authorizes Stock Dividend
Wednesday November 22, 8:02 pm ET
CHICAGO--(BUSINESS WIRE)--James Monroe Corporation (Pink Sheets:JMCP - News) has authorized a stock dividend of its restricted shares of Originally New York, Inc. such that every holder of 2010 shares of the Company's issued and outstanding stock shall be entitled to receive 1 share of Originally New York, Inc. The record date of this dividend is December 12 and the pay date is December 27 of this year.
ONYI Chairman Taylor Moffitt said, "Chris McGovern and I will be leaving to focus on ONYI now, and we are bringing our JMCP shareholders with us. If you want to be in this party, the show's at ONYI. At some point in the future following the dividend, ONYI will be renamed 'James Monroe Capital Corporation.' This train's leaving, and we're all going to OTC BB town."
The dividend stock is unregistered and accordingly would be restricted. Restricted stock cannot be sold for a period of time, such as a year or two. This protects shareholder value. Following the holding period, restricted stock is also subject to selling limits proportionate to the size of the company. This also helps to protect share prices.
James Monroe Capital President Chris McGovern said, "We have our known broker list, and will follow the strictest procedures of accurate dividend practice."
Moffitt commented, "On a less positive note, with this dividend passing value up to shareholders, the soon-to-be-former JMCP will be losing some of its intrinsic value. It has a future that is uncertain. We will announce our plans for it after they have been determined. Overall this is an outstanding reason to give thanks: the dividend will make your net worth go up. However, if you have short-term investment intentions, you should use discretion. Also, shareholders should be advised that if they sell their stock before the execution date, which is yet to be determined by the NASD, they would not get the dividend. In that light, we hypothesize the trading volume to be short-term investors selling while long-term investors are buying. We're happy to gain long-term partners and accommodate the exit of the short-term market players. I hope all shareholders find us worthy of their continued partnership. I will continue to work diligently to care for OUR new company, ONYI. Happy Thanksgiving and God bless."
This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company's limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company's projections or forward-looking statements. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Contact:
James Monroe Capital Corporation, Northbrook, IL
Chris McGovern, 847-418-3848
--------------------------------------------------------------------------------
Source: James Monroe Capital Corporation
Press Release Source: Originally New York, Inc.
Diversified Ethanol A Division of Originally New York, Inc Increases Production Capabilities Due to Demand
Wednesday November 22, 6:44 pm ET
CHICAGO--(BUSINESS WIRE)--Originally New York, Inc (OTCBB:ONYI - News) is making plans to accommodate the production of up to one ethanol plant per month. Competitors currently have a 3 year waiting list, so the company has again reorganized its production facilities. Additional equipment has been added, and the company is interviewing potential recruits from larger ethanol manufacturing companies to begin a possible 24-hour schedule if needed.
ADVERTISEMENT
Diversified Ethanol is located in Iowa, U.S.A., which is the state leaping ahead of the rest in ethanol production. Iowa is producing 3.8 billion liters of ethanol per year, and plans to double that production to 7.6 billion liters per year. This translates to 1.5 billion Euros in 2006, which could go up to 3.3 billion Euros with the new production and a 10% price increase. Location in Iowa is a good thing for Diversified Ethanol because it is right in the middle of the ethanol excitement.
The demand for ethanol has been increasing quickly, similar to when the demand for oil increased. Oil companies have seen their stocks rise because of this demand. As ethanol consumption grows and continues its increasingly legislated growth in the United States, there is demand for many more local ethanol plants, new technology, and related ethanol systems. Diversified Ethanol will design, manufacture, sell, and operate all of these.
The US produced 16 billion liters of ethanol in 2005, and 20 billion liters in 2006, and is still importing ethanol to meet its growing demand. This is about 3% of the gasoline consumption. The US plans to have 7.4% of the gasoline consumption become ethanol by 2012, according to some sources. The government has continued to mandate more ethanol blending, and with the new House of Representatives, it is expected to pass aggressive legislation that favors ethanol.
New Energy Finance, a research firm in London, predicts that the renewable energy sector will swell from a 30 billion Euro industry to a 120 billion Euro industry over the next decade. Blackrock's New Energy Fund, based in Luxemburg, has quickly grown to 3.1 billion Euros and has shown gains of 22% as opposed to Morgan Stanley Capital International's 14%.
For more information about Diversified Ethanol, please visit the company web site at www.diversifiedethanol.com.
This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company's limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company's projections or forward-looking statements. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Contact:
Originally New York, Inc, Eagle Grove, IA
Chris McGovern, 515-603-6292
--------------------------------------------------------------------------------
Source: Originally New York, Inc.
ONYI Press Release Source: Originally New York, Inc.
Diversified Ethanol A Division of Originally New York, Inc Increases Production Capabilities Due to Demand
Wednesday November 22, 6:44 pm ET
CHICAGO--(BUSINESS WIRE)--Originally New York, Inc (OTCBB:ONYI - News) is making plans to accommodate the production of up to one ethanol plant per month. Competitors currently have a 3 year waiting list, so the company has again reorganized its production facilities. Additional equipment has been added, and the company is interviewing potential recruits from larger ethanol manufacturing companies to begin a possible 24-hour schedule if needed.
Diversified Ethanol is located in Iowa, U.S.A., which is the state leaping ahead of the rest in ethanol production. Iowa is producing 3.8 billion liters of ethanol per year, and plans to double that production to 7.6 billion liters per year. This translates to 1.5 billion Euros in 2006, which could go up to 3.3 billion Euros with the new production and a 10% price increase. Location in Iowa is a good thing for Diversified Ethanol because it is right in the middle of the ethanol excitement.
The demand for ethanol has been increasing quickly, similar to when the demand for oil increased. Oil companies have seen their stocks rise because of this demand. As ethanol consumption grows and continues its increasingly legislated growth in the United States, there is demand for many more local ethanol plants, new technology, and related ethanol systems. Diversified Ethanol will design, manufacture, sell, and operate all of these.
The US produced 16 billion liters of ethanol in 2005, and 20 billion liters in 2006, and is still importing ethanol to meet its growing demand. This is about 3% of the gasoline consumption. The US plans to have 7.4% of the gasoline consumption become ethanol by 2012, according to some sources. The government has continued to mandate more ethanol blending, and with the new House of Representatives, it is expected to pass aggressive legislation that favors ethanol.
New Energy Finance, a research firm in London, predicts that the renewable energy sector will swell from a 30 billion Euro industry to a 120 billion Euro industry over the next decade. Blackrock's New Energy Fund, based in Luxemburg, has quickly grown to 3.1 billion Euros and has shown gains of 22% as opposed to Morgan Stanley Capital International's 14%.
For more information about Diversified Ethanol, please visit the company web site at www.diversifiedethanol.com.
This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company's limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company's projections or forward-looking statements. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Contact:
Originally New York, Inc, Eagle Grove, IA
Chris McGovern, 515-603-6292
--------------------------------------------------------------------------------
Source: Originally New York, Inc.
NEWS
Press Release Source: Originally New York, Inc.
Diversified Ethanol A Division of Originally New York, Inc Increases Production Capabilities Due to Demand
Wednesday November 22, 6:44 pm ET
CHICAGO--(BUSINESS WIRE)--Originally New York, Inc (OTCBB:ONYI - News) is making plans to accommodate the production of up to one ethanol plant per month. Competitors currently have a 3 year waiting list, so the company has again reorganized its production facilities. Additional equipment has been added, and the company is interviewing potential recruits from larger ethanol manufacturing companies to begin a possible 24-hour schedule if needed.
Diversified Ethanol is located in Iowa, U.S.A., which is the state leaping ahead of the rest in ethanol production. Iowa is producing 3.8 billion liters of ethanol per year, and plans to double that production to 7.6 billion liters per year. This translates to 1.5 billion Euros in 2006, which could go up to 3.3 billion Euros with the new production and a 10% price increase. Location in Iowa is a good thing for Diversified Ethanol because it is right in the middle of the ethanol excitement.
The demand for ethanol has been increasing quickly, similar to when the demand for oil increased. Oil companies have seen their stocks rise because of this demand. As ethanol consumption grows and continues its increasingly legislated growth in the United States, there is demand for many more local ethanol plants, new technology, and related ethanol systems. Diversified Ethanol will design, manufacture, sell, and operate all of these.
The US produced 16 billion liters of ethanol in 2005, and 20 billion liters in 2006, and is still importing ethanol to meet its growing demand. This is about 3% of the gasoline consumption. The US plans to have 7.4% of the gasoline consumption become ethanol by 2012, according to some sources. The government has continued to mandate more ethanol blending, and with the new House of Representatives, it is expected to pass aggressive legislation that favors ethanol.
New Energy Finance, a research firm in London, predicts that the renewable energy sector will swell from a 30 billion Euro industry to a 120 billion Euro industry over the next decade. Blackrock's New Energy Fund, based in Luxemburg, has quickly grown to 3.1 billion Euros and has shown gains of 22% as opposed to Morgan Stanley Capital International's 14%.
For more information about Diversified Ethanol, please visit the company web site at www.diversifiedethanol.com.
This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company's limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company's projections or forward-looking statements. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Contact:
Originally New York, Inc, Eagle Grove, IA
Chris McGovern, 515-603-6292
--------------------------------------------------------------------------------
Source: Originally New York, Inc.
I had an order in since 1 PM @.0001 and they didn't fill it
hopefully that's a good sign
Got your email and deleted the message, I am working nights this month so I won't be around much during the day.
But thanks Bull
I think you might be the loser, at least financially
jeez .0002 right off the bat......................
Maybe you should put a disclaimer in your posts, because sometimes it looks like you are pumping the s*** out of a stock, as an investor, things are not always positive in a stock, yet you never seem to provide that info, its always positive info, and if both sides are not written, than that makes you a promoter.
But I thought you were holding for $54.00 a share, that's what you were telling everyone else to do, does that mean you sold at $4.00 ?
CMKX AND CSHD do you have anymore hot stock picks, I sure would like to get one.......................
LOL
CNES ConectiSys Strategic Alliance Agreement
Market Wire - November 21, 2006 8:02 AM (EDT)
VALENCIA, CA, Nov 21, 2006 (MARKET WIRE via COMTEX) -- ConectiSys Corporation (OTCBB: CNES), a developer of automatic meter reading technologies, announced today that it has completed an agreement for a Strategic Alliance with Trimark Associates of Folsom, California. Trimark is licensed in California and other states to provide Meter Service Provider (MSP) and Meter Data Management Agent (MDMA) services to commercial, industrial and residential electric customers.
Robert Spigno, the Company's President and CEO, commented that, "This Agreement between the two companies will allow Trimark to provide MDMA and MSP services for ConectiSys. These services will fill a need for ConectiSys and complete the triumvirate of services (meter technology, meter installation and data management and billing) required for ConectiSys to be a full-service AMR provider."
In addition to the MDMA and MSP services, Trimark and ConectiSys, under the guidelines of this alliance, have also agreed to pursue together the following areas of mutual interest:
-- A Joint Marketing effort whereby each company will identify commercial
opportunities for each other's products.
-- Trimark currently builds electric revenue meters for large electric
generation customers in California. ConectiSys and Trimark have agreed to
form a Joint Venture to further develop these meters and their associated
software for deployment throughout the Untied States.
Chairman Spigno further stated, "Trimark's industry related clients are significant and represent a fast track to market. It is anticipated that this relationship will reduce development and marketing costs while offering greater services, which is expected to increase opportunities for both companies."
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein and in the Monthly Report that are not historical are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements including, but not limited to: the level of cost-effectiveness and efficiency of the Company's H-Net(TM) automatic meter reading products or technologies; changes in the Company's policies regarding communications with shareholders and the general public; the success or failure of the Company's marketing efforts and the particular efforts to be employed; the Company's ability or inability to commercialize, sell, license or further develop its H-Net(TM) automatic meter reading products or technologies; and other risks detailed from time to time in the Company's periodic reports and other filings with the Securities and Exchange Commission.
Investor Relations:
Luca S. Spigno
InvestorRelations@ConectiSys.com
(661) 295-6763 ext. 204
SOURCE: ConectiSys Corporation
mailto:InvestorRelations@ConectiSys.com
Copyright 2006 Market Wire, All rights reserved.
I was revisiting one of my loser stocks and found this info,, the stock is TNOG and is currently trading at .0033
Share Structure:
Authorized: 750 Million
Outstanding: 749,753,651 as of 2005-10-05
Float: Approx. 375 Million
So 50 mil AS doesn't mean we couldn't move with the right PR
JMCP
Our structure
Information provided here is accurate as of November 15, 2006 according to the transfer agent.
45,807,012,880 Total Outstanding
50,000,000,000 Authorized
27,567,260,336 Free Trade
18,239,752,544 Restricted
JUST A DREAM
Stocks4john my pick is Indianapolis
and thanks
MODC Press Release Source: Modern Technology Corp
Modern Technology Corp Reports 235 Percent Increase in Quarterly Revenue With $3,085,878 for Quarter Ending September 30, 2006 vs. Same Quarter 2005
Monday November 20, 1:32 pm ET
OXFORD, Miss., Nov. 20, 2006 (PRIMEZONE) -- Modern Technology Corp (Other OTC:MODC.PK - News), a diversified technology development and acquisition company, announced today that during the three months ending September 30, 2006 it generated revenues of $3,085,878 versus $1,311,779 for the three months ended September 30, 2005, an increase of 235%. It also reported assets of $4,774,355. For complete details of the company's Form 10Q-SB filing, please visit the SEC's website at http://www.sec.gov.
Anthony Welch, Chairman, said: ``We anticipate delivering significant new revenues in the coming year from our most recent acquisition as we enter the international market for cancer detection and diagnostics. Our AnuCyte system is the single most accurate method on the planet for detecting cancer and will quickly become the gold standard for all tissue-based cancer diagnostics. Shareholders should continue to expect regular updates on both our progress with AnuCyte and our upcoming stock-dividend.''
More about the cancer diagnostic marketplace:
Prostate Cancer Diagnosis
Prostate tumors with an intermediate histological grade, which represent the majority of prostate tumors, cannot be reliably determined by current clinical laboratory methods. The AnuCyte system can rapidly and accurately test for prostate cancer. The system's test results provide the only clinically useful prognostic information for patients with these intermediate grade tumors.
There are approximately 2 million men living with prostate cancer in the USA, with a growth rate of about 200,000 new cases per year. Based on these figures, the company projects prostate cancer diagnostics revenues of $12 million the first year for the market and over $50 million by the end of the third year.
Cervical cancer diagnosis
Currently, cervical cancer represents a larger market than prostate cancer with 55 million Pap smears collected in the USA annually. The company's entry into this market space will be the competition free market of 2-5 million (and rising) ``ASCUS'' (indeterminate) Pap smears generated annually.
The AnuCyte system is the only system in the world that measures aneuploidy in cervical smears. This measurement is an independent predictor of biological outcome and will sort out the non-cancerous cells, precancerous cells, and cancerous cells in the ASCUS slide's cell population. There is no method at present in clinical laboratories for deciding the status of an ASCUS slide. The AnuCyte system can quickly deliver comprehensive and accurate results for any ASCUS slide. This puts the ASCUS market in the USA at $200-$500 million annually. The company projects cervical cancer diagnostics revenues of $16 million the first year for the market and $50 million by the end of the third year.
Overall Cancer Diagnostic Marketplace
The worldwide market potential is unquantifiable. The 'AnuCyte Cancer Detection System' is not limited to the cancers mentioned above. The system functions for any slide preparation and delivers rapid and accurate results in all suspected cancerous samples. It must be noted that our predictions only cover the USA market. The international market is much larger and will be part of the company's initial marketing efforts alongside the USA.
About the AnuCyte Cancer Detection System
AnuCyte is the only system in the world that can detect all cancers by analyzing the single trait common to all forms of cancer. This trait is not found in any healthy cell. The system rapidly and accurately identifies cancer at any stage in its development and also identifies healthy cancer-free cells in the same test. The system is unique in the world and can be applied to any form of cell sample suspected of cancer and return a reliable test result within minutes. The system completely eliminates heretofore unreliable, subjective, and error-prone pathology diagnosis of cancer and delivers an automated and completely objective measurement of the presence or absence of cancer with the highest accuracy rate of any diagnostic technology in the world. The AnuCyte system is the first and only system in the world that can accurately detect and assess the chromosomal imbalance of cancer in any tissue sample. This ability allows the system to quickly and accurately identify both cancerous and non-cancerous cells.
The inventor of the AnuCyte system, Dr. David Rasnick, PhD and his scientific research collaborator, Dr. Peter Duesberg, PhD, have been prominent names internationally for many years for their research and publications. Investors may wish to read a recent article in Newsweek concerning the cancer research of Dr. Duesberg:
http://www.msnbc.msn.com/id/14757547/site/newsweek/
About Insight Medical Group
Insight Medical Group is a specialized biosciences development company whose mission is to bring world-changing medical technology and research to market in the areas of cancer and AIDS. The AnuCyte Cancer Detection System was invented by Dr. David Rasnick, PhD. The technology behind AnuCyte and the chromosomal imbalance theory is the result of 45 years of combined cancer research by Dr. David Rasnick, PhD and Dr. Peter Duesberg, PhD, who continues his studies on cancer research at the University of California, Berkeley.
About Modern Technology Corp
Modern Technology Corp, a diversified technology development and acquisition company, builds revenues through continuous growth, strategic acquisitions, and commercialization of nascent technology. MODC improves operating efficiencies through the elimination of cost redundancies and realized synergy between subsidiaries. Web Address: http://www.moderntechnologycorp.com
Safe-Harbor Statement
This press release contains statements (such as projections regarding future performance) that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected as a result of certain risks and uncertainties, including but not limited to those detailed from time to time in the Company's filings with the Securities and Exchange Commission.
Contact:
Modern Technology Corp
Investor Relations:
Anthony Welch
(601) 213-3629
ir@moderntechnologycorp.com
--------------------------------------------------------------------------------
Source: Modern Technology Corp
MODC Press Release Source: Modern Technology Corp
Modern Technology Corp Reports 235 Percent Increase in Quarterly Revenue With $3,085,878 for Quarter Ending September 30, 2006 vs. Same Quarter 2005
Monday November 20, 1:32 pm ET
OXFORD, Miss., Nov. 20, 2006 (PRIMEZONE) -- Modern Technology Corp (Other OTC:MODC.PK - News), a diversified technology development and acquisition company, announced today that during the three months ending September 30, 2006 it generated revenues of $3,085,878 versus $1,311,779 for the three months ended September 30, 2005, an increase of 235%. It also reported assets of $4,774,355. For complete details of the company's Form 10Q-SB filing, please visit the SEC's website at http://www.sec.gov.
Anthony Welch, Chairman, said: ``We anticipate delivering significant new revenues in the coming year from our most recent acquisition as we enter the international market for cancer detection and diagnostics. Our AnuCyte system is the single most accurate method on the planet for detecting cancer and will quickly become the gold standard for all tissue-based cancer diagnostics. Shareholders should continue to expect regular updates on both our progress with AnuCyte and our upcoming stock-dividend.''
More about the cancer diagnostic marketplace:
Prostate Cancer Diagnosis
Prostate tumors with an intermediate histological grade, which represent the majority of prostate tumors, cannot be reliably determined by current clinical laboratory methods. The AnuCyte system can rapidly and accurately test for prostate cancer. The system's test results provide the only clinically useful prognostic information for patients with these intermediate grade tumors.
There are approximately 2 million men living with prostate cancer in the USA, with a growth rate of about 200,000 new cases per year. Based on these figures, the company projects prostate cancer diagnostics revenues of $12 million the first year for the market and over $50 million by the end of the third year.
Cervical cancer diagnosis
Currently, cervical cancer represents a larger market than prostate cancer with 55 million Pap smears collected in the USA annually. The company's entry into this market space will be the competition free market of 2-5 million (and rising) ``ASCUS'' (indeterminate) Pap smears generated annually.
The AnuCyte system is the only system in the world that measures aneuploidy in cervical smears. This measurement is an independent predictor of biological outcome and will sort out the non-cancerous cells, precancerous cells, and cancerous cells in the ASCUS slide's cell population. There is no method at present in clinical laboratories for deciding the status of an ASCUS slide. The AnuCyte system can quickly deliver comprehensive and accurate results for any ASCUS slide. This puts the ASCUS market in the USA at $200-$500 million annually. The company projects cervical cancer diagnostics revenues of $16 million the first year for the market and $50 million by the end of the third year.
Overall Cancer Diagnostic Marketplace
The worldwide market potential is unquantifiable. The 'AnuCyte Cancer Detection System' is not limited to the cancers mentioned above. The system functions for any slide preparation and delivers rapid and accurate results in all suspected cancerous samples. It must be noted that our predictions only cover the USA market. The international market is much larger and will be part of the company's initial marketing efforts alongside the USA.
About the AnuCyte Cancer Detection System
AnuCyte is the only system in the world that can detect all cancers by analyzing the single trait common to all forms of cancer. This trait is not found in any healthy cell. The system rapidly and accurately identifies cancer at any stage in its development and also identifies healthy cancer-free cells in the same test. The system is unique in the world and can be applied to any form of cell sample suspected of cancer and return a reliable test result within minutes. The system completely eliminates heretofore unreliable, subjective, and error-prone pathology diagnosis of cancer and delivers an automated and completely objective measurement of the presence or absence of cancer with the highest accuracy rate of any diagnostic technology in the world. The AnuCyte system is the first and only system in the world that can accurately detect and assess the chromosomal imbalance of cancer in any tissue sample. This ability allows the system to quickly and accurately identify both cancerous and non-cancerous cells.
The inventor of the AnuCyte system, Dr. David Rasnick, PhD and his scientific research collaborator, Dr. Peter Duesberg, PhD, have been prominent names internationally for many years for their research and publications. Investors may wish to read a recent article in Newsweek concerning the cancer research of Dr. Duesberg:
http://www.msnbc.msn.com/id/14757547/site/newsweek/
About Insight Medical Group
Insight Medical Group is a specialized biosciences development company whose mission is to bring world-changing medical technology and research to market in the areas of cancer and AIDS. The AnuCyte Cancer Detection System was invented by Dr. David Rasnick, PhD. The technology behind AnuCyte and the chromosomal imbalance theory is the result of 45 years of combined cancer research by Dr. David Rasnick, PhD and Dr. Peter Duesberg, PhD, who continues his studies on cancer research at the University of California, Berkeley.
About Modern Technology Corp
Modern Technology Corp, a diversified technology development and acquisition company, builds revenues through continuous growth, strategic acquisitions, and commercialization of nascent technology. MODC improves operating efficiencies through the elimination of cost redundancies and realized synergy between subsidiaries. Web Address: http://www.moderntechnologycorp.com
Safe-Harbor Statement
This press release contains statements (such as projections regarding future performance) that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected as a result of certain risks and uncertainties, including but not limited to those detailed from time to time in the Company's filings with the Securities and Exchange Commission.
Contact:
Modern Technology Corp
Investor Relations:
Anthony Welch
(601) 213-3629
ir@moderntechnologycorp.com
--------------------------------------------------------------------------------
Source: Modern Technology Corp
OT : Lottery Numbers Match OSU Game Score Sun Nov 19, 8:40 AM ET
The score for the Buckeyes game may have been extra lucky for some people.
There was an interesting twist or coincidence in the score for Saturday's winning lottery numbers.
The winning score for the game was Ohio State 42 to 39. NewsChannel5 is the Ohio Lottery station, and after the game, the numbers were chosen at the station for the Pick 4 drawing.
The winning numbers were: 4, 2, 3, 9 -- the same as the score.
Ohio state 42 Michigan 39 Yeeeeeeee Haaaaaaaaaaaaaaa
My pick is Pittsburgh
thanks
or End Of Message
I really appreciate the posters here, you guys have been great, you have made it to 39th place on the most read board
http://www.investorshub.com/boards/most_read.asp
Press Release Source: Modern Technology Corp
Modern Technology Corp Chairman Talks to Wall Street Reporter About Insight Medical Group
Wednesday November 15, 3:53 pm ET
OXFORD, Miss., Nov. 15, 2006 (PRIMEZONE) -- Modern Technology Corp (Other OTC:MODC.PK - News), a diversified technology development and acquisition company announced today its Chairman was interviewed by Wall Street Reporter. Mr. Welch used this forum to inform the company's shareholders about the exciting developments in progress with its new subsidiary, Insight Medical Group and the AnuCyte Cancer Detection system.
To hear the entire interview, visit http://www.wallstreetreporter.com. ``Recent Interviews' right-side menu of web page.
AnuCyte is the only system in the world that can detect all cancers by analyzing the single trait common to all forms of cancer. This trait is not found in any healthy cell. The system rapidly and accurately identifies cancer at any stage in its development and also identifies healthy cancer-free cells in the same test. The system is unique in the world and can be applied to any form of cell sample suspected of cancer and return a reliable test result within minutes. The system completely eliminates heretofore unreliable, subjective, and error-prone pathology diagnosis of cancer and delivers an automated and completely objective measurement of the presence or absence of cancer with the highest accuracy rate of any diagnostic technology in the world. The AnuCyte system is the first and only system in the world that can accurately detect and assess the chromosomal imbalance of cancer in any tissue sample. This ability allows the system to quickly and accurately identify both cancerous and non-cancerous cells.
Dr. Rasnick and Dr. Duesberg have been prominent names internationally for many years for their research and publications. Investors may wish to read a recent article in Newsweek concerning the cancer research of Dr. Duesberg:
http://www.msnbc.msn.com/id/14757547/site/newsweek/
About Insight Medical Group
Insight Medical Group is a specialized biosciences development company whose mission is to bring world-changing medical technology and research to market in the areas of cancer and AIDS. The AnuCyte Cancer Detection System was invented by Dr. David Rasnick, Ph.D. The technology behind AnuCyte and the chromosomal imbalance theory is the result of 45 years of combined cancer research by Dr. David Rasnick, Ph.D. and Dr. Peter Duesberg, Ph.D., who continues his studies on cancer research at the University of California, Berkeley.
About Modern Technology Corp
Modern Technology Corp, a diversified technology development and acquisition company, builds revenues through continuous growth, strategic acquisitions, and commercialization of nascent technology. MODC improves operating efficiencies through the elimination of cost redundancies and realized synergy between subsidiaries. Web Address: http://www.moderntechnologycorp.com
Safe-Harbor Statement
This press release contains statements (such as projections regarding future performance) that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected as a result of certain risks and uncertainties, including but not limited to those detailed from time to time in the Company's filings with the Securities and Exchange Commission.
Contact:
Modern Technology Corp
Investor Relations:
Anthony Welch
(601) 213-3629
ir@moderntechnologycorp.com
--------------------------------------------------------------------------------
Source: Modern Technology Corp
My girlfriends X husband is diagnosed with schizophrenia, and makes a ton of money in the market, now I now why
for what its worth the IBOX has been updated with all recent Pr's
Press Release Source: Modern Technology Corp
Modern Technology Corp Announces Significant Appointment to Insight Medical Group's Scientific Advisory Panel
Monday November 13, 11:39 am ET
OXFORD, Miss., Nov. 13, 2006 (PRIMEZONE) -- Modern Technology Corp (Other OTC:MODC.PK - News), a diversified technology development and acquisition company, announced today the immediate appointment to the Scientific Advisory Board of its bioscience operating subsidiary, Insight Medical Group, Mr. James S. Hartinger, MBA, CT (ASCP).
ADVERTISEMENT
Mr. Hartinger, an industry veteran in cytopathology for 22 years, brings 12 years experience managing a major cytology lab, plus his national reputation as an expert in the diagnosis of human cancers. He was involved in 3 clinical trials of automated cytology machines. He collaborated with the major cancer diagnostic companies Cytyc, Tripath, Digene, and Neopath. Mr. Hartinger played a central role developing the AnuCyte cancer diagnostics system.
Mr. Hartinger brings vast experience and knowledge in the field of cancer diagnostics emanating from clinical work, cancer research, and product development. Mr. Hartinger maintains close relationships with executive and technical arms of all the major clinical labs, diagnostics companies, and HMOs. He has his finger on the pulse of the cancer diagnostics field.
Mr. Hartinger's close association with Insight Medical Group will provide the players in the field with the confidence and integrity they look for in considering a new approach to cancer diagnosis.
Some of his many publications include the following:
1. Bishop JW, Hartinger JS, Pawlick GS. Time Interval effect on
repeat Pap Smears. Acta Cytol. 1997;41(2):269-276
2. Manos M, Kinney WD, Hurely LB, Sherman ME, Shieh-Ngai J, Kurman
RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick
GF, Hiatt RA. Identifying Women with Cervical Neoplasia Using
Human Papillomavirus DNA testing for equivocal Pap results. JAMA
1999; 281: 1605-1610
3. Determining the Utility and Effectiveness of the Neopath AutoPap
300 QC System Used Routinely. Barbara Fetterman, S.C.T. (ASCP),
Gene Pawlick, M.D., Howard Koo, M.S., M.T. (ASCP), James
Hartinger, CT(ASCP), Carol Gilbert, CT(ASCP), C.M.I.A.C., and
Sheryl Connell. ACTA 1999
Anthony Welch, Chairman, said: ``Mr. Hartinger is a stunning addition to an already world-class team. We are honored to include such an eminent name to the company's growing team. Dr. David Rasnick and Dr. Peter Duesberg have worked closely with Mr. Hartinger on the development of the AnuCyte system and Mr. Hartinger is a strong supporter of their work. He is a powerful ally for the company and the introduction of the AnuCyte cancer detection services to the international community of clinical and pathology labs. We have a historic technology and a team second to none.''
AnuCyte is the only system in the world that can detect all cancers by analyzing the single trait common to all forms of cancer. This trait is not found in any healthy cell. The system rapidly and accurately identifies cancer at any stage in its development and also identifies healthy cancer-free cells in the same test. The system is unique in the world and can be applied to any form of cell sample suspected of cancer and return a reliable test result within minutes. The system completely eliminates heretofore unreliable, subjective, and error-prone pathology diagnosis of cancer and delivers an automated and completely objective measurement of the presence or absence of cancer with the highest accuracy rate of any diagnostic technology in the world. The AnuCyte system is the first and only system in the world that can accurately detect and assess the chromosomal imbalance of cancer in any tissue sample. This ability allows the system to quickly and accurately identify both cancerous and non-cancerous cells.
Dr. Rasnick and Dr. Duesberg have been prominent names internationally for many years for their research and publications. Investors may wish to read a recent article in Newsweek concerning the cancer research of Dr. Duesberg:
http://www.msnbc.msn.com/id/14757547/site/newsweek/
About Insight Medical Group
Insight Medical Group is a specialized biosciences development company whose mission is to bring world-changing medical technology and research to market in the areas of cancer and AIDS. The AnuCyte Cancer Detection System was invented by Dr. David Rasnick, Ph.D. The technology behind AnuCyte and the chromosomal imbalance theory is the result of 45 years of combined cancer research by Dr. David Rasnick, PhD and Dr. Peter Duesberg, Ph.D, who continues his studies on cancer research at the University of California, Berkeley.
About Modern Technology Corp
Modern Technology Corp, a diversified technology development and acquisition company, builds revenues through continuous growth, strategic acquisitions, and commercialization of nascent technology. MODC improves operating efficiencies through the elimination of cost redundancies and realized synergy between subsidiaries. Web Address: http://www.moderntechnologycorp.com
Safe-Harbor Statement
This press release contains statements (such as projections regarding future performance) that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected as a result of certain risks and uncertainties, including but not limited to those detailed from time to time in the Company's filings with the Securities and Exchange Commission.
Contact:
Modern Technology Corp
Anthony Welch
Investor Relations:
(601) 213-3629
ir@moderntechnologycorp.com
--------------------------------------------------------------------------------
Source: Modern Technology Corp
MODC Press Release Source: Modern Technology Corp
Modern Technology Corp Announces Significant Appointment to Insight Medical Group's Scientific Advisory Panel
Monday November 13, 11:39 am ET
OXFORD, Miss., Nov. 13, 2006 (PRIMEZONE) -- Modern Technology Corp (Other OTC:MODC.PK - News), a diversified technology development and acquisition company, announced today the immediate appointment to the Scientific Advisory Board of its bioscience operating subsidiary, Insight Medical Group, Mr. James S. Hartinger, MBA, CT (ASCP).
Mr. Hartinger, an industry veteran in cytopathology for 22 years, brings 12 years experience managing a major cytology lab, plus his national reputation as an expert in the diagnosis of human cancers. He was involved in 3 clinical trials of automated cytology machines. He collaborated with the major cancer diagnostic companies Cytyc, Tripath, Digene, and Neopath. Mr. Hartinger played a central role developing the AnuCyte cancer diagnostics system.
Mr. Hartinger brings vast experience and knowledge in the field of cancer diagnostics emanating from clinical work, cancer research, and product development. Mr. Hartinger maintains close relationships with executive and technical arms of all the major clinical labs, diagnostics companies, and HMOs. He has his finger on the pulse of the cancer diagnostics field.
Mr. Hartinger's close association with Insight Medical Group will provide the players in the field with the confidence and integrity they look for in considering a new approach to cancer diagnosis.
Some of his many publications include the following:
1. Bishop JW, Hartinger JS, Pawlick GS. Time Interval effect on
repeat Pap Smears. Acta Cytol. 1997;41(2):269-276
2. Manos M, Kinney WD, Hurely LB, Sherman ME, Shieh-Ngai J, Kurman
RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick
GF, Hiatt RA. Identifying Women with Cervical Neoplasia Using
Human Papillomavirus DNA testing for equivocal Pap results. JAMA
1999; 281: 1605-1610
3. Determining the Utility and Effectiveness of the Neopath AutoPap
300 QC System Used Routinely. Barbara Fetterman, S.C.T. (ASCP),
Gene Pawlick, M.D., Howard Koo, M.S., M.T. (ASCP), James
Hartinger, CT(ASCP), Carol Gilbert, CT(ASCP), C.M.I.A.C., and
Sheryl Connell. ACTA 1999
Anthony Welch, Chairman, said: ``Mr. Hartinger is a stunning addition to an already world-class team. We are honored to include such an eminent name to the company's growing team. Dr. David Rasnick and Dr. Peter Duesberg have worked closely with Mr. Hartinger on the development of the AnuCyte system and Mr. Hartinger is a strong supporter of their work. He is a powerful ally for the company and the introduction of the AnuCyte cancer detection services to the international community of clinical and pathology labs. We have a historic technology and a team second to none.''
AnuCyte is the only system in the world that can detect all cancers by analyzing the single trait common to all forms of cancer. This trait is not found in any healthy cell. The system rapidly and accurately identifies cancer at any stage in its development and also identifies healthy cancer-free cells in the same test. The system is unique in the world and can be applied to any form of cell sample suspected of cancer and return a reliable test result within minutes. The system completely eliminates heretofore unreliable, subjective, and error-prone pathology diagnosis of cancer and delivers an automated and completely objective measurement of the presence or absence of cancer with the highest accuracy rate of any diagnostic technology in the world. The AnuCyte system is the first and only system in the world that can accurately detect and assess the chromosomal imbalance of cancer in any tissue sample. This ability allows the system to quickly and accurately identify both cancerous and non-cancerous cells.
Dr. Rasnick and Dr. Duesberg have been prominent names internationally for many years for their research and publications. Investors may wish to read a recent article in Newsweek concerning the cancer research of Dr. Duesberg:
http://www.msnbc.msn.com/id/14757547/site/newsweek/
About Insight Medical Group
Insight Medical Group is a specialized biosciences development company whose mission is to bring world-changing medical technology and research to market in the areas of cancer and AIDS. The AnuCyte Cancer Detection System was invented by Dr. David Rasnick, Ph.D. The technology behind AnuCyte and the chromosomal imbalance theory is the result of 45 years of combined cancer research by Dr. David Rasnick, PhD and Dr. Peter Duesberg, Ph.D, who continues his studies on cancer research at the University of California, Berkeley.
About Modern Technology Corp
Modern Technology Corp, a diversified technology development and acquisition company, builds revenues through continuous growth, strategic acquisitions, and commercialization of nascent technology. MODC improves operating efficiencies through the elimination of cost redundancies and realized synergy between subsidiaries. Web Address: http://www.moderntechnologycorp.com
Safe-Harbor Statement
This press release contains statements (such as projections regarding future performance) that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected as a result of certain risks and uncertainties, including but not limited to those detailed from time to time in the Company's filings with the Securities and Exchange Commission.
Contact:
Modern Technology Corp
Anthony Welch
Investor Relations:
(601) 213-3629
ir@moderntechnologycorp.com
--------------------------------------------------------------------------------
Source: Modern Technology Corp
The realists take charge in Washington
POSTED: 5:12 a.m. EST, November 12, 2006
By Joe Klein
Time
The following is a summary of this week's Time magazine cover story.
(Time.com) -- This was a big deal. Certainly, it was the end of George W. Bush's radical experiment in partisan governance. It might have been even bigger than that: the end of the conservative pendulum swing that began with Ronald Reagan's revolution.
Not only did the Democrats lay a robust whupping on the Republicans in the midterm elections, but -- far worse -- the president was forced into a tacit acknowledgment that the defining policy of his administration, the war in Iraq, was failing.
In 1994, when Bill Clinton lost both houses of Congress, he merely replaced his consultants and, liberated from the liberal wing of his party, sailed into the enforced moderation of divided government.
Last week Bush replaced Donald Rumsfeld, the blustery symbol of American arrogance overseas -- and, after six years of near total control at home, had to adjust to a situation in which his vision had been rejected by the voters and his power seriously truncated.
Rumsfeld was replaced by Robert Gates, who had been a junior associate on the foreign policy team of President George H.W. Bush and was well schooled in the cautious "realism" that marked the reign of Bush the Elder.
In fact, if there was a common strand in last week's Democratic victories and Republican defeats, it was the ascendancy of realists. The architects of the Democratic victory, Sen. Charles Schumer and Rep. Rahm Emanuel, had calculated with cold-eyed efficiency which candidates the party would support, regardless of the extent of their orthodoxy.
On the Republican side, realists seemed to be taking over the national security apparatus -- even if was not yet clear that the president would follow their advice.
Bush's decision to delay the sacking of Rumsfeld until after the election will undoubtedly stand as one of the greatest mistakes of his presidency.
It was a purely political decision, straight from the Karl Rove playbook: Show no sign of weakness or indecision in the midst of a campaign -- or, as Bill Clinton neatly summarized it, Strong and wrong beats weak and right.
Not this time. "Strong and wrong" may have cost Bush the election. It may also have cost him whatever chance he had for a dignified exit from Iraq. His refusal to change his team and his strategy prevented an effective response to the centrifugal disintegration of Iraq over the past few months.
The exit polls indicate that the war was not the main issue in the 2006 election. The general odor of corruption and incompetence emanating from Washington seemed to be the real motivator.
But the administration's stubbornness on Iraq, neatly symbolized by Rumsfeld's detachment from reality, certainly didn't help the GOP cause. Of course, it is assumed by most people in Washington that bipartisan efforts on even the smallest matters, much less the war in Iraq, will be near impossible.
You've heard the arguments: the House of Representatives will be controlled by ancient liberals of Vietnam vintage, just itching to investigate and indict; Bush has shown precious little inclination toward compromise in his various moral crusades -- tax cuts, Social Security reform, the war -- and Dick Cheney has shown even less.
The standard post-election gestures toward peace and bipartisanship certainly seemed more starchy than genuine. The president opened his press conference with an ironic shot at the media, "Why all the glum faces?" If Jane Austen were writing a novel about Bush's public aspect, the title would be "Pride and Petulance."
But for the sake of argument and in the hope that sanity will prevail, let me make a mild case for optimism.
First, there is the muscular realism of the Democrats who ran the election campaigns, Schumer and Emanuel. They chose their candidates on pragmatism, not principle. Yes, many of the winners tended to be moderates, but that's because this was an election, especially on the House side, waged in moderate districts.
The question now is whether "winning" means blocking the president or demonstrating the ability to govern. It probably means a little of both, but I suspect the Democrats will be better served by proving they have the maturity to do the latter.
Why? Because the American public proved that it had the maturity to ignore, and in many cases rebel against, the sludge tide of negative ads that was splashed onto the public airwaves, primarily by Republicans.
This election was not only about a disastrous war and the stench of corruption, it was also about a style of politics -- the slashing negative politics practiced by a generation of media consultants in both parties. It was a message to politicians: Stop slinging the manure, and start getting serious about the nation's problems.
If Rufus had a lawyer that's exactly what would be happening
this is why
$500 to the person who guesses the closest time to when post #15M happens.
$75 to both the folks who post prior and after the 15M post.
$100 to the person who posts the 15M post.